Do European patients’ enjoy freedom of movement within the EU, to receive the best treatment available in the Union?
The approval of the Directive 2011/24/EU on the application of patient’s right in cross-border healthcare in 2011 (commonly known as the Cross Border Healthcare Directive – CBHD) gave hope to many patients in Europe seeking better healthcare.
The answer to our question, however, is more complex than expected. In the following presentation, ECPC Vice President Kathi Apostolidis guides you through the impact of the CBHD in the wider perspective of cancer patients mobility in Europe.